Dr. Hoehn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
New York
New York, NY 10019- Is this information wrong?
Education & Training
- University of Texas M D Anderson Cancer CenterHematopathology, 2010 - 2012
- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Pathology-Anatomic and Clinical, 2006 - 2010
- Montefiore Medical Center/Albert Einstein College of MedicineResidency, Surgery, 2005 - 2006
- Johannes Gutenberg University of Mainz Faculty of MedicineClass of 2004
Certifications & Licensure
- NY State Medical License 2012 - 2026
- NY State Medical License 2014 - 2024
- PA State Medical License 2009 - 2018
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 19 citationsDaratumumab plus RVd for newly diagnosed multiple myeloma: final analysis of the safety run-in cohort of GRIFFIN.Peter M. Voorhees, Cesar Rodriguez, Brandi Reeves, Nitya Nathwani, Luciano J. Costa, Yana Lutska, Padma Bobba, Daniela Hoehn, Huiling Pei, Jon Ukropec, Ming Qi, Thomas...> ;Blood Advances. 2021 Feb 23
- 344 citationsDaratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trialPeter M. Voorhees, Jonathan L. Kaufman, Jacob P. Laubach, Douglas W. Sborov, Brandi Reeves, Cesar Rodriguez, Ajai Chari, Rebecca Silbermann, Luciano J. Costa, Larry D....> ;Blood. 2020 Aug 20
- 6 citationsEffects of High- and Low-LET Radiation on Human Hematopoietic System Reconstituted in Immunodeficient MiceDaniela Hoehn, Monica Pujol-Canadell, Erik F. Young, Geo Serban, Igor Shuryak, Jennifer Maerki, Zheng Xu, Mashkura Chowdhury, Aesis M. Luna, George Vlada, Lubomir B. S...> ;Radiation Research. 2018 Dec 6
- Join now to see all
Abstracts/Posters
- Daratumumab (DARA) Maintenance Therapy Improves Depth of Response and Results in Durable Progression-free Survival (PFS) Following DARA plusCyclophosphamide, Bortezomi...Robert M. Rifkin, Jason Melear, Edward Faber, William I. Bensinger, John M. Burke, Mohit Narang, Don Stevens,Sriya Gunawardena, Daniela Hoehn, Yana Lutska, Keqin Qi, ..., ASH 2019, Orlando, 12/9/2019
- Depth of Response to Daratumumab (DARA), Lenalidomide, Bortezomib, and Dexamethasone (RVd) Improves over Time in Patients (pts) with Transplant-Eligible Newly Diagnose...Daniela Hoehn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: